4//SEC Filing
Lawton Alison Frances 4
Accession 0000899243-23-018867
CIK 0001690585other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 9:17 PM ET
Size
9.7 KB
Accession
0000899243-23-018867
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 totalExercise: $11.20Exp: 2033-09-10→ Common Stock (6,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 9:17 PM ET
- Size
- 9.7 KB